⁍ The European Commission will spend 220 million euros to move COVID-19 patients across borders of the 27-nation bloc.
⁍ The Commission is in talks with four companies to secure potential COVID vaccines.
⁍ EU has already secured potential vaccines being developed by AstraZeneca, Sanofi and Johnson & Johnson.
– The European Union plans to spend $266 million to try to stop the spread of swine flu across its borders, Reuters reports. “The spread of the virus will overwhelm our healthcare systems if we do not act urgently,” says the head of the EU’s commission. The money will be used to move COVID-19 patients across borders in an effort to prevent health systems in the most affected countries from collapsing. Meanwhile, the EU is in talks with four companies for potential vaccines, after securing deals with other three, says the commission’s head. “The spread of the virus will overwhelm our healthcare systems if we do not act urgently,” says the head of the EU’s commission. She also said the EU would work for the quick validation, at EU level, of rapid antigen tests and that the Commission was in talks with four companies to secure potential COVID vaccines, after it had already sealed supply deals with other three. The EU has already secured potential vaccines being developed by AstraZeneca, Sanofi, Johnson & Johnson. It has also said to be in talks with Moderna, CureVac and a partnership of Pfizer and BionTech The EU Commission also said it will work to have a common passenger locator form by the end of the year to trace travelers in the bloc.
Source: https://www.reuters.com/article/us-health-coronavirus-eu-overwhelmed/eu-to-fund-transfer-of-covid-patients-across-borders-to-prevent-hospitals-collapse-idUSKBN27E3K3